Fortis Healthcare Share Price

Fortis Health.

CMP as on 19-Oct-21 12:11

₹ 262.60
-0.10 -0.04%

Open

₹ 262.70

Turnover (lac)

₹ 3,622

Prev. Close

₹ 262.70

Day's Vol (shares)

₹ 13,79,257

Day's Range (₹)

₹ 253.90
₹ 264.90

CMP as on19-Oct-21 12:08

₹ 262.75
0.05 0.02%

Open

₹ 260.50

Turnover (lac)

₹ 1,625

Prev. Close

₹ 262.70

Day's Vol (shares)

₹ 86,210

Day's Range

₹ 253.85
₹ 264.40

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 06-Aug-2021 - -
FORTIS HEALTHCARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2021 inter alia to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 notice is hereby given that a meeting of the Board of Directors of the Company will be held on Friday August 13 2021 to inter-alia consider and approve un-audited financial results for the quarter ended June 30 2021. Further in continuation to our letter ref. FHL/SEC/2021-22 dated June 29 2021 captioned Closure of Trading Window it is hereby informed that the trading window of the Company for dealing in securities of the Company will remain closed till August 15 2021. This is for your information and record please. Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e. August 13, 2021, inter-alia, considered and approved standalone and consolidated un-audited financial results of the Company for the period ended on June 30, 2021 along with limited review report thereon. Accordingly, please find enclosed standalone and consolidated un-audited financial results along with limited review report given by the Statutory Auditor of the Company for period ended on June 30, 2021. Further, a copy of the press release and investor presentation being issued in this regard is also enclosed. The meeting commenced at 1100 Hours IST and concluded at 1740 Hours IST. This is for your information and records please. (As per BSE Announcement Dated on 13/8/2021)
Board Meeting - 22-May-2021 - -
FORTIS HEALTHCARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2021 ,inter alia, to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, notice is hereby given that a meeting of the Board of Directors of the Company will be held on Saturday, May 29, 2021 to, inter-alia, consider and approve audited financial results for the year ended March 31, 2021. Further, in continuation to our letter ref. FHL/SEC/2020-21 dated March 31, 2021 captioned Closure of Trading Window, it is hereby informed that the trading window of the Company for dealing in securities of the Company will remain closed till May 31, 2021. This is for your information and record please. Dear Sir(s), Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today inter-alia, considered and approved the Audited Standalone and Consolidated Financial results of the Company for the quarter and financial year ended March 31, 2021. M/s B S R and Co. LLP, the Statutory Auditors of the Company have issued an Audit Report with modified opinion along with Statement of impact of Modified Opinion thereon; Accordingly, please find enclosed Audited standalone and consolidated financial results along with audit report along with Statement of impact of Modified Opinion given by the Statutory Auditor of the Company for year ended March 31, 2021. Further, a copy of the press release and investor presentation being issued in this regard is also enclosed. The meeting commenced at 12 Noon and concluded at 18:10 Hours IST. T Please find enclosed Audited standalone and consolidated financial results along with audit report along with Statement of impact of Modified Opinion given by the Statutory Auditor of the Company for year ended March 31, 2021. Further, a copy of the press release and investor presentation being issued in this regard is also enclosed. (As per BSE Announcement Dated on 29/05/2021)
Board Meeting - 31-Mar-2021 - -
Dear Sir(s), Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today, inter-alia, considered and approved the appointment of Mr. Joerg Ayrle (DIN- 09128449), as an Additional Director (Non-Executive) of the Company with immediate effect. He will hold the office up to the next Annual General Meeting and will be regularized subject to the approval of the shareholders. Brief Profile of Mr. Joerg Ayrle is attached as Annexure 1. Further, there is no inter-se relationship between Mr. Joerg Ayrle and other Directors. Mr. Joerg Ayrle has declared that he is not debarred from accessing the capital markets and / or restrained from holding any position / office of Director in a Company pursuant to order of SEBI or any other such authority. The Board Meeting commenced at 1200 Hours and concluded at 1735 Hours.
Board Meeting - 29-Jan-2021 - -
FORTIS HEALTHCARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2021 ,inter alia, to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, notice is hereby given that a meeting of the Board of Directors of the Company will be held on Friday, February 5, 2021 to, inter-alia, consider and approve un-audited financial results for the quarter ended December 31, 2020. Further, in continuation to our letter ref. FHL/SEC/2020-21 dated December 30, 2020 captioned Closure of Trading Window, it is hereby informed that the trading window of the Company for dealing in securities of the Company will remain closed till February 7, 2021. This is for your information and record please. The detailed disclosure is attached for your refrence. The detailed disclosures as required under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 is enclosed. (As per BSE Announcement Dated on 5/2/2021)
Board Meeting - 05-Nov-2020 - -
FORTIS HEALTHCARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2020 ,inter alia, to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, notice is hereby given that a meeting of the Board of Directors of the Company will be held on Thursday, November 12, 2020 to, inter-alia, consider and approve un-audited financial results for the quarter and period ended September 30, 2020. Further, in continuation to our letter ref. FHL/SEC/2020-21 dated September 29, 2020 captioned Closure of Trading Window, it is hereby informed that the trading window of the Company for dealing in securities of the Company will remain closed till November 14, 2020. This is for your information and record please. Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e. November 12, 2020, inter-alia, considered and approved standalone and consolidated un-audited financial results of the Company for the period ended on September 30, 2020 along with limited review report thereon. Accordingly, please find enclosed standalone and consolidated un-audited financial results along with limited review report given by the Statutory Auditor of the Company for period ended on September 30, 2020 and copy of the press release and investor presentation being issued in this regard. The Board Meeting commenced at 1200 Noon and concluded at 1930 Hours. (As per BSE Announcement Dated on 12/11/2020)
Open ZERO Brokerage Demat Account